reported post-close Monday inconclusive results for a phase IIb clinical trial of AZD3480 to treat mild to moderate...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALZHEIMER'S
Given that 26 million people worldwide have Alzheimer's disease and 106 million could be afflicted by 2050, any treatment that alters the course of the disease will become a multi-billion-dollar drug. Major pharmaceutical companies and biotech startups are racing to develop the first drugs to delay or reverse Alzheimer’s. Medical device makers are also developing screening tests to more accurately diagnose Alzheimer’s, and health care providers are trying to find ways to better manage patients.
Alzheimer's is part of Business Exchange, suggested by
Cathy Arnst.
This topic contains
1,254 news
and
1,153 blog
items.
Read updated news, blogs, and resources about Alzheimer's. Find user-submitted articles and reactions on Alzheimer's from
like-minded professionals.
News
Please add new articles to this topic
Inc. on Monday announced disappointing results for a midstage trial of a treatment the companies are developing for...
- AstraZeneca Plc (AZN.L: Quote, Profile, Research, Stock Buzz) said on Monday that a study of the experimental...
Protein that regulates Tau may protect aging brains, giving mroe credence to Tau hypothesis
that results from the Phase 2b clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in mild to moderate...
More evidence that a spinal fluid enzyme may be a diagnostic marker for Alzheimer's disease
that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
a punishment or to control behavior. Sarasota, Fla.: What are the most promising drugs on the horizon for Alzheimer's...
sister, Terry, and me never to put her in a care facility. But at 93, she had advancing dementia and was living in L.A.
People who eat a strict Mediterranean diet are at less risk of developing heart disease, cancer, Parkinson's and...
University of Melbourne in Australia did randomized tests on 170 adults age 50 or older who didn't have dementia but...
By taking a new tack in fighting the disease, a tiny Sinagapore startup may have the jump on Big Pharma
molecular diagnostics business. The pharmaceutical unit received a one-time payment of $100 million for development of...
for protecting the brain as people age and that missing one copy may boost the likelihood of developing Alzheimer's...
because Francesco Bellini dared to bypass the all-powerful U.S. Food and Drug Administration (FDA) and sell Bellus's...
our memory,' said study author Anna Vogiatzoglou, MSc, with the University of Oxford. Brain atrophy is associated with...
the design of new therapeutic approaches tackling developmental delay, mental retardation, ageing and regeneration of...
has been on the rise thanks to articles that have touted the compound as a possible treatment for Alzheimer's disease,...
the design of new therapeutic approaches tackling developmental delay, mental retardation, aging and regeneration of...
being reported Friday in the journal Science, is likely to open a new avenue in the investigation of Alzheimer's...
SCOTTSDALE, Ariz., Sept. 8 /PRNewswire/ -- MedPredict has published a new report entitled 'Thought Leader Insight &...
A number of recent failures and mixed clinical trial results for Alzheimer's disease drug candidates doesn't seem to...
D Murali Chennai: Few diseases have had as great a social, economic, and personal impact as Alzheimer's, the most...
experimental drugs in the offing, Pfizer decided to upgrade its own arsenal by making a deal for an Alzheimer's drug...
climbed to an all-time high Wednesday after the company struck a marketing agreement with Pfizer Inc. for the...
Top Sources: Alzheimer's
- alzheimersreadingroom.com
- Reuters
- US News
- New York Times
- Mail Online UK
- Los Angeles Times
- Boston Globe
- sciencedaily.com
- rttnews.com
- MarketWatch
account